Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection

被引:89
作者
Kato, K
Shimozato, O
Hoshi, K
Wakimoto, H
Hamada, H
Yagita, H
Okumura, K
机构
[1] JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,TOKYO 113,JAPAN
[2] JAPANESE FDN CANC RES,INST CANC,CTR CANC CHEMOTHERAPY,DEPT MOL BIOTHERAPY RES,TOKYO 170,JAPAN
关键词
antagonist; myoblast transplantation;
D O I
10.1073/pnas.93.17.9085
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p40 subunit of interleukin 12 (IL-12p40) has been known to act as an IL-12 antagonist in vitro. We here describe the immunosuppressive effect of IL-12p40 in vivo. A murine myoblast cell line, C2C12, was transduced with retrovirus vectors carrying the lacZ gene as a marker and the IL-12p40 gene, IL-12p40 secreted from the transfectant inhibited the IL-12-induced interferon gamma (IFN-gamma) production by splenocytes in vitro. Survival of C2C12 transplanted into allogeneic recipients was substantially prolonged when transduced with IL-12p40, Cytokine (IL-2 and IFN-gamma) production and cytotoxic T lymphocyte induction against allogeneic C2C12 were impaired in the recipients transplanted with the IL-12p40 transfectant. Delayed-type hypersensitivity response against C2C12 was also diminished in the IL-12p40 recipients. Furthermore, serum antibodies against beta-galactosidase of the T-helper 1-dependent isotypes (IgG2 and IgG3) were decreased in the IL-12p40 recipients, These results indicate that locally produced IL-12p40 exerts a potent immunosuppressive effect on T-helper 1-mediated immune responses that lead to allograft rejection. Therefore, IL-12p40 gene transduction would be useful for preventing the rejection of allografts and genetically modified own cells that are transduced with potentially antigenic molecules in gene therapy.
引用
收藏
页码:9085 / 9089
页数:5
相关论文
共 32 条
[1]   DIFFERENTIAL EXPRESSION OF MESSENGER-RNA ENCODING INTERLEUKIN-12 P35 AND P40 SUBUNITS IN-SITU [J].
BETTE, M ;
JIN, SC ;
GERMANN, T ;
SCHAFER, MKH ;
WEIHE, E ;
RUDE, E ;
FLEISCHER, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2435-2440
[2]   DUCHENNE MUSCULAR-DYSTROPHY - DEFICIENCY OF DYSTROPHIN AT THE MUSCLE-CELL SURFACE [J].
BONILLA, E ;
SAMITT, CE ;
MIRANDA, AF ;
HAYS, AP ;
SALVIATI, G ;
DIMAURO, S ;
KUNKEL, LM ;
HOFFMAN, EP ;
ROWLAND, LP .
CELL, 1988, 54 (04) :447-452
[3]   INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS [J].
CHAN, SH ;
PERUSSIA, B ;
GUPTA, JW ;
KOBAYASHI, M ;
POSPISIL, M ;
YOUNG, HW ;
WOLF, SF ;
YOUNG, D ;
CLARK, SC ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :869-879
[4]  
CHIZZONITE R, 1991, J IMMUNOL, V147, P1548
[5]   OVEREXPRESSION OF DYSTROPHIN IN TRANSGENIC MDX MICE ELIMINATES DYSTROPHIC SYMPTOMS WITHOUT TOXICITY [J].
COX, GA ;
COLE, NM ;
MATSUMURA, K ;
PHELPS, SF ;
HAUSCHKA, SD ;
CAMPBELL, KP ;
FAULKNER, JA ;
CHAMBERLAIN, JS .
NATURE, 1993, 364 (6439) :725-729
[6]   CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION [J].
DAI, YF ;
SCHWARZ, EM ;
GU, DL ;
ZHANG, WW ;
SARVETNICK, N ;
VERMA, IM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (05) :1401-1405
[7]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[8]   GENE-THERAPY FOR HEMOPHILIA-A - PRODUCTION OF THERAPEUTIC LEVELS OF HUMAN FACTOR-VIII IN-VIVO IN MICE [J].
DWARKI, VJ ;
BELLONI, P ;
NIJJAR, T ;
SMITH, J ;
COUTO, L ;
RABIER, M ;
CLIFT, S ;
BERNS, A ;
COHEN, LK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) :1023-1027
[9]  
FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511
[10]  
GATELY MK, 1991, J IMMUNOL, V147, P874